Contents
The Aetna Medicare Advantage broker kickbacks lawsuit alleges that the insurer paid brokers for enrollments under marketing labels and used payments to limit enrollment of people with disabilities. The government’s complaint follows that money into invoices, sales targets and call-routing decisions. For someone who worked on those systems, the revealing detail is what happened when the paperwork slipped: an Aetna executive rejected an invoice’s sales-based description, but the complaint says Aetna ultimately paid it.
A former eHealth executive brought the qui tam case, and the Justice Department joined it on May 1, 2025. The government alleges that Aetna, Elevance Health, formerly Anthem, and Humana paid eHealth, GoHealth and SelectQuote hundreds of millions of dollars in kickbacks from 2016 through at least 2021.
The government’s Medicare Advantage fraud complaint describes brokers directing beneficiaries toward insurers that paid the most, organizing agents into teams that sold only certain insurers’ plans, and sometimes refusing to sell plans whose insurers did not pay enough. Aetna and Humana also allegedly used the payments to pressure brokers to enroll fewer beneficiaries with disabilities, whom the insurers viewed as less profitable.
This broker case is separate from Aetna’s $117.7 million coding settlement announced in March 2026. That settlement resolved allegations about one-way chart reviews and inaccurate morbid-obesity diagnosis codes. The broker story concerns who got enrolled, who was kept out, and what the insurer paid to produce that result.
The complaint alleges that Aetna’s marketing arrangements counted applications and completed sales even when the agreements described lead generation. The distinction matters inside a brokerage: a lead is a potential customer, while an issued policy is the sale the insurer wanted.
The Centers for Medicare & Medicaid Services describes broker compensation as generally beginning with an initial payment and continuing with renewal payments at half that amount if the member stays enrolled.
Agencies also provide the technology, marketing and administrative support behind the sale. The Private Equity Stakeholder Project’s 2024 report, How Private Equity Gets Its Cut From Medicare Advantage, describes both brokers and agencies contracting with multiple insurers and earning commissions and other payments for enrollments. The report contrasts capped broker commissions with uncapped add-on payments for marketing and administrative work. That distinction explains why the payment label matters.
The government’s complaint quotes an Aetna executive explaining how the company could keep the agreement’s language separate from its internal measurement:
[i]t’s really semantics in the agreements. They have to be built around lead generation but we can do all of the counting of apps inside.
Aetna executive’s words quoted in the government’s complaint, United States ex rel. Shea v. eHealth, et al., Complaint in Partial Intervention, paragraph 403
The complaint also describes a proposal to replace policy-based invoices with mathematically equivalent lead-based invoices.
The mismatch became explicit in an April 6, 2020 approval email about SelectQuote. According to the complaint, the invoice was “for 1,954 Issued Sales @ $215 per sale totaling $420,110.” An Aetna executive refused to approve an invoice for sales, calling that noncompliant. The government then alleges that Aetna paid it anyway.
The invoice named the unit Aetna was allegedly buying. The objection shows that someone inside the company recognized why that description mattered.
The complaint also describes payment tiers that rewarded additional Aetna sales. In a comparison involving SelectQuote, the government alleges that Aetna paid $290 for each incremental sale between 19,000 and 25,000 enrollments, while Humana paid $194 per sale. It says SelectQuote shifted sales toward Aetna and other insurers.
Another quoted Aetna proposal offered uncapped marketing fees for sales above enrollment goals. The same distinction runs through a GoHealth manager’s objection quoted in the complaint: reconciling a lead-generation payment against a failure to write policies effectively made it payment for issued policies.
For finance and partner-management staff, that reconciliation is a revealing part of the arrangement. The contract might name leads. The calculation that increased or reduced the payment could still depend on policies sold.
The government alleges that Aetna tied marketing money to brokers’ enrollment mix, threatening to withhold it when the share of beneficiaries with disabilities exceeded the company’s preferred level. The complaint describes the age mix as something employees could monitor and change through the sales channel.
According to the complaint, Aetna told eHealth that payment would depend on an under-65 enrollment share of 27% or below, while saying that the percentage should stay out of the contract.
The complaint follows the pressure into the software. It alleges that, after an urgent Aetna request, eHealth changed its agent quoting tool in June 2016 to filter Aetna plans by age. Depending on the caller’s state and date of birth, agents could no longer offer those plans, even where the plans would have suited the beneficiary. Another passage describes an agreement to keep Aetna plans visible but disable the enrollment button.
The restrictions also reached incoming calls. The government quotes Clearlink’s president telling Aetna that the broker had installed filters rejecting all calls and leads from consumers under 65 on the campaigns in question. The Aetna executive’s response approved the change.
A caller could be screened out before speaking with an agent, or an agent could see a plan without being able to enroll the caller in it. The payment condition and the software setting belonged to the same enrollment process.
Aetna’s internal messages in the complaint include objections to reducing disabled enrollment through sales partners. A sales executive warned colleagues against discussing under-65 improvement with any partner and described the topic as inappropriate. The executive’s own distinction was pointed:
This should be about the appropriate management of these members, not the management of the salesforce.
Aetna sales executive’s words quoted in the government’s complaint, United States ex rel. Shea v. eHealth, et al., Complaint in Partial Intervention, paragraph 556
The complaint also quotes an eHealth executive repeatedly objecting to pressure from Aetna to screen beneficiaries. Those messages matter because they show disagreement inside the companies about what the sales instructions meant.
In another Aetna email exchange, the complaint quotes an executive connecting disabled enrollment to losses and customer complaints, then describing restricting volume as the available response. Read alongside the internal warning, that is the business choice at issue: addressing members’ needs or reducing how many of those members the brokers brought in.
The complaint alleges that steering changed which plans beneficiaries were offered and sometimes put them in plans poorly matched to their needs. A SelectQuote sales manager, quoted in the filing, said competing plans offered better benefits for its largely low-income customers, while Aetna’s reimbursement approach to certain benefits required spending those customers could not afford.
The government also cites Aetna’s internal accounts of complaints about GoHealth enrollments and about enrollment without consent, provider-network representations and other sales representations. These complaints describe consequences that a sales total alone would miss: whether the beneficiary wanted the plan, could use its providers or could afford how its benefits worked.
The American Institutes for Research’s 2026 report explains how insurers can pay more despite commission limits:
MA organizations can sidestep financial caps on agent and broker compensation by adding “administrative payments.”
Medicare Advantage Fraud, Waste, and Abuse Policy Options, American Institutes for Research, 2026
Agents and brokers do not represent every plan, and payments can differ between insurers and between plans. The report finds that enrollment compensation and administrative payments may influence both the information agents share and the plans they present.
It also identifies gaps in the transparency of lead generation and discusses the risk of agents selectively targeting people whose expected use of care is low relative to the insurer’s payment. In the Aetna allegations, that selection has a concrete form: an enrollment-mix condition, a date-of-birth filter and a plan an agent cannot enroll someone in. The policy analysis explains the incentive. The complaint supplies the alleged decisions.
Oak Street Health’s $60 million settlement in September 2024 concerned a different destination for the same sales channel. The government alleged that the health care provider paid insurance agents, typically $200 per beneficiary, to refer people to its clinics through a phone transfer or electronic submission.
There, the alleged payment bought a referral to a provider. Here, the government alleges that insurers bought plan enrollments and influence over which beneficiaries brokers brought them. In both settings, the agent’s recommendation had value to a healthcare business receiving Medicare-funded patients. The useful question inside the business is what event actually earned the payment.
The government’s False Claims Act theory connects the broker arrangements to Medicare’s payments to insurers. The complaint alleges that insurers submitted beneficiary information and compliance statements while concealing enrollments obtained through kickbacks. It separately alleges that Aetna and Humana concealed discriminatory enrollment practices in those submissions.
The invoice and reconciliation can show what earned the money, while the quoting-tool change or call filter can show what the broker did in response. Connecting those decisions to Medicare’s payments is where the case is built.
Someone in finance may see the payment while someone in product operations sees the disabled button. We work with insiders to connect those views to the enrollments and the Medicare payment trail. The complaint’s detail shows why knowledge of the business can matter as much as the wording of its marketing agreement.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
If you handled broker payments, enrollment targets or the rules that kept certain callers out, speak to one of our whistleblower experts about what those payments bought. We build your Medicare Advantage whistleblower case around the sales decisions and Medicare payments, bringing in whistleblower lawyers who know broker kickbacks. You have a partner from the first conversation through the pursuit of a recovery.